Nexstim Bags Order for Navigated Brain Stimulation System in US
Nexstim (NXTMH.HE) secured an order for its Navigated Brain Stimulation 6 system from a US-based customer, according to a Friday release. The Finnish medical technology company said the client will use the device, which is approved for the treatment of major depressive disorder, for therapeutic applications.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.